Erbitux 100 mg/20 ml

Erbitux 100 mg/20 ml is a medicine authorised by Swissmedic under authorisation number 56072. The authorisation holder is Merck (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 01 December 2003 and the authorisation is valid without a time limit. ATC code L01FE01 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 56072
  • ATC L01FE01
  • Biotechnological medicines
Authorisation data
Authorisation number56072
NameErbitux 100 mg/20 ml
Full nameErbitux 100 mg/20 ml, Infusionslösung
Authorisation holderMerck (Schweiz) AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01FE01
First authorisation01 December 2003
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
2Erbitux 100 mg/20 ml, InfusionslösungA01 October 2007
3Erbitux 500 mg/100 ml, InfusionslösungA15 September 2014

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
31 x 20mlL01FE0107.16.1.A
21 x 100mlL01FE0107.16.1.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Erbitux 100 mg/20 ml authorised in Switzerland?

Yes. Erbitux 100 mg/20 ml is authorised by Swissmedic under authorisation number 56072, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Erbitux 100 mg/20 ml have?

Erbitux 100 mg/20 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Erbitux 100 mg/20 ml?

The authorisation holder is Merck (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com